ArticleJournal of nephrology2019

Cyclooxygenase 2 inhibition slows disease progression and improves the altered renal lipid mediator profile in the Pkd2

Md Monirujjaman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.